InsiderClue

Transactions

One row for every decision an insider filed. Open-market buying and selling only. Vesting, grants and the shares withheld to pay the tax on them are not decisions.

Views

Save your view. Keep the filter you have built, and get an email when a new filing matches it. A free account does both.

Create an account Sign in
Companies 0/25
Result 36,603 decisions over 12 months
Reset filters
Direction ?
Both36,603 Bought13,190 Sold23,413
Sort by ?
Most recent Largest amount Share of holding
Window ?
1 mo 12 mo
Plan ?
Any Discretionary Scheduled (10b5-1) Not stated
Minimum amount ?
Any $100K $1M $10M $100M $500M
Share of their own holding ?
What the chief executive holds ?
Plan: Discretionary
Company
Date
Insider
Role
Action ?
Shares
Amount
Of holding
JYNT JOINT Corp
21 Apr 2026
JOBSON CHARLES E
10% owner
Bought
509
$4.37K
0.0%
SNWV SANUWAVE Health, Inc.
21 Apr 2026
Opaleye Management Inc.
10% owner indirect
Sold at will
202
$4.14K
0.0%
KPTI Karyopharm Therapeutics Inc.
21 Apr 2026
Rangwala Reshma
EVP & Chief Medical Officer
Sold at will
449
$4.01K
0.8%
JRSH Jerash Holdings (US), Inc.
21 Apr 2026
Lee Gilbert K.
Chief Financial Officer
Sold at will
400
$1.33K
7.4%
BCDA BioCardia, Inc.
21 Apr 2026
Altman Peter
President and CEO
Bought
400
$492.00
0.1%
TPL Texas Pacific Land Corporation
21 Apr 2026
HORIZON KINETICS ASSET MANAGEMENT LLC
10% owner
Bought
1
$441.84
0.0%
IOR INCOME OPPORTUNITY REALTY INVESTORS INC /TX/
21 Apr 2026
TRANSCONTINENTAL REALTY INVESTORS INC
10% owner
Bought
1
$17.98
0.0%
ASX ASE Technology Holding Co., Ltd.
20 Apr 2026
Chen Tien-Szu
GM, ASE Inc. Chung-Li Branch
Sold at will 4×
530,000
$247.14M
19.1%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
Kaplan Andrew T.
Director indirect
Bought
8,398,438
$134.38M
47.0%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
BAIN CAPITAL INVESTORS LLC
10% owner indirect
Bought
8,398,438
$134.38M
47.0%
TRAX First Tracks Biotherapeutics, Inc.
20 Apr 2026
EcoR1 Capital, LLC
10% owner indirect
Bought
4,705,575
$65.00M
opened
CRWV CoreWeave, Inc.
20 Apr 2026
Magnetar Financial LLC
10% owner indirect
Sold at will 12×
319,835
$37.53M
53.3%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
Bain Capital Life Sciences Investors, LLC
10% owner indirect
Bought
1,562,500
$25.00M
7.4%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
Koppel Adam
Director indirect
Bought
1,562,500
$25.00M
7.4%
RDW Redwire Corp
20 Apr 2026
AE RED HOLDINGS, LLC
Director indirect
Sold at will
1,766,372
$18.07M
7.3%
KLRA Kailera Therapeutics, Inc.
20 Apr 2026
RTW INVESTMENTS, LP
10% owner indirect
Bought
500,000
$8.00M
4.9%
PAM Pampa Energy Inc.
20 Apr 2026
Mindlin Marcos Marcelo
Director
Sold at will
1,250,000
$4.29M
8.2%
ASX ASE Technology Holding Co., Ltd.
20 Apr 2026
Chen Jeffrey
Director indirect
Sold at will
9,000
$4.15M
7.0%
ALMR Alamar Biosciences, Inc.
20 Apr 2026
Naclerio Nicholas
Director indirect
Bought
235,294
$4.00M
86.6%
ALMR Alamar Biosciences, Inc.
20 Apr 2026
Illumina Innovation Fund II GP, L.L.C.
10% owner indirect
Bought
235,294
$4.00M
86.6%
TRV Travelers Companies (The)
20 Apr 2026
Klein Michael Frederick
EVP & President, Personal Ins.
Sold at will 2×
10,000
$3.04M
18.1%
VOR Vor Biopharma Inc.
20 Apr 2026
RA CAPITAL MANAGEMENT, L.P.
Director indirect
Sold at will
171,963
$2.71M
6.3%
LEVI LEVI STRAUSS & CO
20 Apr 2026
Singh Harmit J
EVP & Chief Fin. & Growth Ofc.
Sold at will
110,000
$2.53M
28.9%
FLWS 1 800 FLOWERS COM INC
20 Apr 2026
Fund 1 Investments, LLC
10% owner indirect
Sold at will 3×
543,195
$2.50M
10.1%
MS Morgan Stanley
20 Apr 2026
GROSSMAN ERIC F
Chief Legal/Admin Officer
Sold at will 2×
11,118
$2.12M
6.2%
TRV Travelers Companies (The)
20 Apr 2026
Klenk Jeffrey P.
EVP & Pres., Bond & Spec. Ins.
Sold at will
6,414
$1.96M
51.4%
AGX ARGAN INC
20 Apr 2026
Collins Charles Edwin IV
CHIEF EXECUTIVE OFFICER, GEMMA
Sold at will
2,500
$1.53M
7.6%
AEHR AEHR TEST SYSTEMS
20 Apr 2026
SALAMONE ALBERTO
EVP, PPBI BUSINESS
Sold at will
15,000
$1.34M
19.2%
JBL Jabil
20 Apr 2026
Priestley Andrew
EVP, Chief Operations Officer
Sold at will
3,169
$1.05M
5.3%
GPRK GeoPark Ltd
20 Apr 2026
PARK JAMES FRANKLIN
Director
Sold at will
100,000
$882.90K
9.9%
TRV Travelers Companies (The)
20 Apr 2026
Kurtzman Diane
EVP & Chief HR Officer
Sold at will 2×
2,867
$869.98K
35.1%
CTAS Cintas
20 Apr 2026
TYSOE RONALD W
Director
Sold at will
4,666
$834.61K
17.2%
AEHR AEHR TEST SYSTEMS
20 Apr 2026
ROGERS VERNON
Exec VP of Sales & Mktg.
Sold at will 2×
7,431
$668.79K
4.8%
AEHR AEHR TEST SYSTEMS
20 Apr 2026
POSEDEL RHEA J
Director indirect
Sold at will
7,500
$660.68K
1.9%
RM Regional Management Corp.
20 Apr 2026
Forager Fund, L.P.
10% owner
Sold at will
15,000
$595.20K
1.5%
LWAY Lifeway Foods, Inc.
20 Apr 2026
SMOLYANSKY LUDMILA
Member of 10% owner group indirect
Sold at will
15,000
$397.50K
2.0%
ADBE Adobe Inc.
20 Apr 2026
Durn Daniel
EVP & CFO
Sold at will
1,336
$331.35K
3.0%
FITB Fifth Third Bancorp
20 Apr 2026
Khanna Kevin J
EVP
Sold at will 2×
6,000
$304.63K
7.3%
MSTR Strategy Inc
20 Apr 2026
Patten Jarrod M
Director
Sold at will 2×
1,500
$250.42K
5.1%
ECAT BlackRock ESG Capital Allocation Term Trust
20 Apr 2026
Saba Capital Management, L.P.
10% owner indirect
Sold at will
13,782
$201.49K
0.1%
PTGX Protagonist Therapeutics, Inc
20 Apr 2026
Ali Asif
Chief Financial Officer
Sold at will
1,750
$184.57K
2.9%
NNBR NN INC
20 Apr 2026
Corre Partners Management, LLC
10% owner indirect
Sold at will 2×
79,757
$178.84K
11.7%
NNBR NN INC
20 Apr 2026
Barrett John Frederick
10% owner indirect
Sold at will
79,757
$178.84K
1.4%
GSBC GREAT SOUTHERN BANCORP, INC.
20 Apr 2026
Bugh John M
Vice President of Subsidiary
Sold at will
2,500
$168.98K
58.3%
VTIX Virtuix Holdings Inc.
20 Apr 2026
Goetgeluk Jan Roger
Chief Executive Officer
Sold at will
24,990
$165.43K
0.6%
STIM Neuronetics, Inc.
20 Apr 2026
Chernett Jorey
10% owner
Bought
100,000
$158.00K
1.0%
IMDX Insight Molecular Diagnostics Inc.
20 Apr 2026
BROADWOOD PARTNERS, L.P.
10% owner
Bought
40,690
$157.97K
0.3%
SPRU SPRUCE POWER HOLDING CORP
20 Apr 2026
STEEL PARTNERS HOLDINGS L.P.
10% owner indirect
Bought
24,335
$100.42K
0.7%
QSI Quantum-Si Inc
20 Apr 2026
Hawkins Jeffrey Alan
President & CEO
Sold at will
83,712
$84.25K
2.2%
ONCO Onconetix, Inc.
20 Apr 2026
HRT FINANCIAL LP
10% owner
Sold at will
94,462
$70.85K
53.1%
Showing 17,151–17,200 of 36,603. ← Newer Page 344 of 733 Older →